In patients with heart failure with preserved ejection fraction (HFpEF), sodium-glucose co-transporter 2 inhibitors (SGLT2i) improve prognosis and symptoms. To evaluate the short-term effects of SGLT2i on myocardial extracellular volume (ECV) and left ventricular (LV) function in patients with HFpEF and diabetes mellit...
A. Marathonitis, A. Anastasiou, N. Vythoulkas-Biotis et al.· Scientific Reports· 0 citations
It is argued that clinical value will depend on closed-loop workflows in which multimodal predictions are experimentally validated, externally tested, and longitudinally updated to guide the next therapeutic decision.
K. Papavassiliou, A. Sofianidi, Angeliki Margoni et al.· International Journal of Mol...· 0 citations
The findings identify structural PKD2 variation as an under-recognized cause of genetically unresolved late-onset ADPKD and demonstrate that phenotype-guided incorporation of copy number analysis can overcome limitations of NGS alone.
Akrivi Papachristopoulou, Angeliki Margoni, A. Simoudis et al.· Medicina· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.